Pregnolia
Zürich, CH · 1 known investors
Find your way into Pregnolia
Sign up to see every warm intro you have to Pregnolia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pregnolia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pregnolia has developed a medical device that measures cervical stiffness to help health care providers assess cervical status in pregnancy care. The technology originated from research at ETH Zürich and University Hospital Zürich and is being studied as a potential biomarker for preterm birth.
Investors · 1
In the news
Frequently asked questions
- What does Pregnolia do?
- Pregnolia has developed a medical device that measures cervical stiffness to help health care providers assess cervical status in pregnancy care. The technology originated from research at ETH Zürich and University Hospital Zürich and is being studied as a potential biomarker for preterm birth.
- Who are Pregnolia's investors?
- Pregnolia's investors include Neventa Capital.
- Where is Pregnolia headquartered?
- Pregnolia is headquartered in Zürich, CH.